US panel urges heart risk warning on ADHD drugs
Posted on: Thursday, 9 February 2006, 15:50 CST
GAITHERSBURG, Maryland (Reuters) - Prescription drugs to treat attention deficit disorder should come with strong 'black-box' warnings that they may increase the risk of heart problems in some patients, a U.S. advisory panel said on Thursday.
The Food and Drug Administration committee voted 8-7 in favor of the warning, with one abstention. Fifteen members also voted to recommend the drugs, which include Novartis AG's Ritalin and Shire Pharmaceuticals Group Plc's Adderall, be dispensed with a patient-friendly guide that explained possible side effects.
Source: REUTERS
Related Articles
Rating: 3.1 / 5 (10 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds